UK Healthcare Analytics Market 2026 | Worth USD 11.2 Billion by 2034, at a CAGR of 21.71%.

Market Overview

The UK healthcare analytics market is advancing rapidly, driven by widespread adoption of predictive analytics tools, growing use of artificial intelligence (AI) and machine learning (ML) to improve patient care, rising deployment of population health management (PHM) solutions, and large-scale national data infrastructure programs across the NHS. The market size reached USD 1.8 Billion in 2025 and is projected to reach USD 11.2 Billion by 2034, growing at a compound annual growth rate (CAGR) of 21.71% from 2026 to 2034.

Demand is being reinforced by strong workforce sentiment and public-sector policy. According to a 2024 Health Foundation article, 76% of NHS staff support the use of AI to improve patient care and 81% favor it for administrative work. In 2023, the NHS announced plans for what it described as the world's largest healthcare data platform, bringing together health data sources to inform decisions and patient outcomes. NHS England's Medium Term Planning Framework 2026/27–2028/29 expects all providers and integrated care boards to onboard to the NHS Federated Data Platform and use its core products and population health management tools by 2028/29, giving vendors a clear policy-backed demand signal through the forecast period.

Request a Sample Report for In-Depth Market Insights: https://www.imarcgroup.com/uk-healthcare-analytics-market/requestsample

UK Healthcare Analytics Market Summary

• The UK healthcare analytics market reached USD 1.8 Billion in 2025 and is expected to reach USD 11.2 Billion by 2034, reflecting a 21.71% CAGR during 2026-2034.
• [Predictive Analysis] leads the type segment with a [XX]% share in 2025, supported by adoption of tools that use EHR, medical device, and wearable data to anticipate health complications before they occur.
• [Cloud-based] delivery leads the delivery mode segment with a [XX]% share in 2025, while on-premises and web-hosted models retain a role in data-sensitive environments.
• [London] leads regionally with a [XX]% share in 2025, anchored by its concentration of academic medical centers, NHS trusts, and health-technology developers.
• A 2024 Health Foundation article found that 76% of NHS staff support AI for patient care and 81% support it for administrative work, a workforce-readiness indicator underpinning adoption of AI-driven analytics.
• NHS England expects all providers and ICBs to onboard to the Federated Data Platform by 2028/29, making national platform adoption a structural demand driver through the forecast period.

Porter's Five Forces Analysis – UK Healthcare Analytics Market

Competitive Rivalry: Moderate to High. Global data and analytics specialists, electronic health record vendors, cloud providers, and consulting-led integrators compete for NHS and life science workloads. The Federated Data Platform contract was awarded to a Palantir-led consortium alongside Accenture, PwC, NECS, and Carnall Farrar, and rivals compete on specialized clinical, financial, and operational use cases around it.

Supplier Power (Technology and Infrastructure Providers): Moderate to High. Dependence on a small number of platform, cloud, and analytics-software providers gives suppliers leverage, and critics have argued that vendor lock-in and dependency on a single supplier for software and expertise is a significant risk that undermines local decision-making.

Buyer Power (NHS Bodies, Payers, and Life Science Companies): High. NHS England and integrated care boards are large, centralized, and politically accountable buyers. The Federated Data Platform contract's first term ends in March 2027, and continuing beyond that point requires the Department of Health and Social Care to actively trigger an extension, illustrating how much leverage public buyers hold over contract structure and continuity.

Threat of Substitutes: Low to Moderate. In-house NHS analytics teams, existing trust-level business intelligence tools, and secure data environments can substitute for external platforms in some use cases. However, the breadth of predictive, prescriptive, and population-level analytics required at national scale limits full substitution.

Threat of New Entrants: Moderate. University spin-outs and specialized AI developers can enter through narrow clinical use cases, as shown by tools such as Foresight. However, information-governance requirements, security assurance, NHS procurement processes, and public scrutiny of data use raise barriers for platform-scale entrants.

Market Growth Drivers

Increasing Adoption of Predictive Analytics Tools

The UK healthcare analytics market is becoming central to healthcare delivery, helping providers improve patient conditions, optimize resources, and reduce service costs. By analyzing data from electronic health records (EHRs), medical devices, fitness bands, and other sources, healthcare analytics tools seek to anticipate health complications before they occur. Companies and regulatory bodies are developing predictive tools specifically for healthcare. In 2023, the NHS announced plans to build what it described as the world's largest healthcare data platform, bringing together health data sources to improve decision-making and patient outcomes.

Expanding Use of Population Health Management Solutions

Population health management (PHM) solutions have become increasingly important in the UK health service because they use data on health-related factors to improve outcomes across entire populations. The approach aligns with the NHS's long-term goal of shifting toward a more preventative care model, and vendors have introduced PHM tools that identify at-risk populations, manage chronic conditions, and lower care costs. In 2024, collaborative research led by the University of Oxford produced QR4, a tool that predicts an individual's 10-year risk of cardiovascular diseases such as stroke. NHS England's planning framework directs integrated care boards to use the population health management suite of the Federated Data Platform for strategic commissioning, embedding PHM in system-level planning.

Growth in Artificial Intelligence and Machine Learning Integration

AI and ML are driving innovation across diagnostics, treatment recommendations, and operational efficiency. A 2024 Health Foundation article reported that 76% of NHS staff support the use of AI to improve patient care and 81% favor its use in administrative work. AI-driven analytics is reducing human error in diagnostics, personalizing treatment through data-driven insights, and supporting faster decisions that can shorten patient waiting times. In 2023, the Accelerated Capability Environment (ACE) worked with the NHS AI Lab to develop an AI tool that identifies patients at risk of prolonged hospital stays, aimed at improving outcomes and reducing costs.

National Data Platform Investment and Policy Mandates

Central investment in shared data infrastructure is reshaping demand for healthcare analytics. A Palantir-led consortium was awarded the NHS Federated Data Platform contract in November 2023, and the contract runs to 2030 with a reported maximum value of £330 million as more trusts adopt the platform. The platform uses a federated architecture in which each NHS organisation operates its own separate tenant, an approach designed to connect fragmented operational data while keeping local control. Adoption remains contested, and Greater Manchester ICB reported that it decided not to use the platform, which shows that vendor selection and governance will shape how quickly demand converts.

UK Healthcare Analytics Market Segmentation

Type Insights

• Descriptive Analysis
• Predictive Analysis
• Prescriptive Analysis

Component Insights

• Software
• Hardware
• Services

Delivery Mode Insights

• On-Premises
• Web-hosted
• Cloud-based

Application Insights

• Clinical
• Financial
• Operational and Administrative

End-Use Insights

• Healthcare Payers
• Healthcare Providers
• Life Science Companies

Regional Insights

• London
• South East
• North West
• East of England
• South West
• Scotland
• West Midlands
• Yorkshire and The Humber
• East Midlands
• Others

Competitive Landscape

The UK healthcare analytics market combines global data-platform vendors, health IT and life science analytics providers, consulting-led integrators, and academic and start-up innovators. Competition centers on national platform contracts, clinical AI use cases, PHM tooling, and cloud-based delivery. Strategy is increasingly shaped by NHS procurement decisions, data-governance expectations, and scrutiny of supplier concentration.

Key players:

• Palantir Technologies (NHS Federated Data Platform, Foundry)
• Accenture
• PwC
• NECS
• Carnall Farrar
• [Additional EHR, analytics, and cloud vendors from the full report]
• Vibrant Wellness (precision lab testing)
• Academic and NHS research consortia (King's College London, UCL, University of Oxford, NHS foundation trusts)

NHS England awarded Imperial College Projects a £700,000 contract to evaluate the Federated Data Platform, running from March 2026 to 2029, assessing whether it meets its objectives, delivers value for money, and creates measurable impact. The contract's break clause could be triggered in early 2027, before the full evaluation is complete, making 2026-27 a pivotal period for competitive positioning. In May 2024, Vibrant Wellness announced its expansion into the UK to offer precision lab testing, combining biotechnology, academic research, and software solutions.

Regional Analysis

London: London is expected to anchor demand through its concentration of teaching hospitals, research universities, and health-technology developers. In March 2024, researchers at King's College London, UCL, King's College Hospital NHS Foundation Trust, and Guy's and St Thomas' NHS Foundation Trust developed and tested Foresight, an AI tool that identifies complex patterns in health data to predict patients' future health.

South East: The South East benefits from proximity to London and from leading research institutions. The 2024 University of Oxford-led QR4 tool, which predicts 10-year cardiovascular risk, demonstrates the region's contribution to predictive and preventative analytics.

North West: Greater Manchester and Liverpool combine large provider networks with active digital-health policy debate. Greater Manchester ICB confirmed a decision not to use the Federated Data Platform, showing that regional platform strategies can diverge from national programs.

Scotland: NHS Scotland operates within a devolved health system, and the Federated Data Platform is a programme of NHS England. Scottish demand is therefore shaped by separate procurement and data strategies.

East of England, South West, West Midlands, Yorkshire and The Humber, East Midlands, and Others: These regions are expected to grow as integrated care boards adopt population health management and performance-management tools under the 2026/27–2028/29 planning framework. Region-level shares and growth rates: [XX]%.

Recent Industry Developments

• July 2026: The NHS announced £10 billion in funding over three years for technology, digital and data-system upgrades. The investment is expected to generate around £41 billion in benefits over the next decade, supporting AI, data analytics, a Single Patient Record and digital health infrastructure.
• July 2026: NHS trials of AI-enabled clinical documentation showed that ambient voice technology could free clinicians to spend nearly 25% more time with patients. At St George’s Hospital, the technology saved clinicians an average of 47 minutes per shift, enabling each clinician to see approximately one additional patient per shift.
• July 2026: More than 500,000 NHS staff were given access to Microsoft Copilot following trials that reduced administrative workloads by an average of two days per month per worker, highlighting increasing use of AI-supported data processing and analytics across NHS operations.
• June 2026: The UK government reviewed its £330 million NHS contract with Palantir for data-management and analytics services. The contract, originally signed in 2023, covers a potential seven-year term, making it one of the UK's significant public-sector healthcare data-analytics deployment

Key Takeaways for the UK Healthcare Analytics Market

• Market Performance: USD 1.8 Billion (2025) → USD 11.2 Billion (2034), with [Predictive Analysis] leading the type segment at [XX]% and [London] leading regionally at [XX]%.
• Market Outlook: A 21.71% CAGR through 2034 reflects rapid value growth driven by predictive analytics adoption, AI and ML integration, PHM solutions, and national data platform mandates.
• Growth Drivers: Predictive analytics tools using EHR and device data; PHM tools supporting the NHS shift to prevention; strong NHS staff support for AI (76% for patient care, 81% for administration); and national platform adoption expected by 2028/29.
• Competitive Landscape: Platform vendors, integrators, and academic innovators compete around national contracts and clinical AI use cases, with 2026-27 contract decisions shaping positioning.
• Value Chain Analysis: From health data generation (EHRs, medical devices, wearables) through data integration and platform infrastructure, analytics software and AI models, service and implementation partners, to delivery of insights for clinical, financial, and operational decisions by payers, providers, and life science companies.
• Industry Trends: Growth of predictive and prescriptive analytics; federated data architectures; AI tools for diagnostics and risk prediction; and rising scrutiny of data governance and supplier concentration.
• Strategic Recommendations: Develop clinically validated predictive and PHM solutions aligned with NHS planning priorities; build interoperability with federated platform architectures; invest in transparent data governance to address public and professional concerns; and pursue partnerships with academic and NHS research institutions to accelerate AI validation and adoption.

Note: If you need any specific information that is not currently covered within the scope of the report, we will provide the same as a part of customization.

Speak to an analyst: https://www.imarcgroup.com/request?type=report&id=29122&flag=C

Browse Other Reports by IMARC Group:

UK Pharmaceutical Market: https://www.imarcgroup.com/uk-pharmaceutical-market

UK Pharmaceuticals Export Market: https://www.imarcgroup.com/uk-pharmaceuticals-export-market

UK AI in Healthcare Market: https://www.imarcgroup.com/uk-ai-in-healthcare-market

About Us

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group

134 N 4th St, Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201-971-6302